rosmarinic-acid and Diabetes-Mellitus--Type-1

rosmarinic-acid has been researched along with Diabetes-Mellitus--Type-1* in 1 studies

Other Studies

1 other study(ies) available for rosmarinic-acid and Diabetes-Mellitus--Type-1

ArticleYear
Phenethyl ester of rosmarinic acid attenuates autoimmune responses during type 1 diabetes development in mice.
    Life sciences, 2022, Jan-01, Volume: 288

    Rosmarinic acid (RA) is a polyphenol that occurs in plants of the Lamiaceae family. Phenethyl ester of RA (PERA), a novel RA derivative, has been developed and evaluated in vivo in an animal model of type 1 diabetes (T1D).. T1D was induced in male C57BL/6 mice using multiple low doses of streptozotocin (STZ) administered intraperitoneally for 5 consecutive days. Intraperitoneal administration of PERA (2.5 mg/kg bw) began from the first STZ injection and continued for 20 days.. PERA-treated mice exhibited lower incidence of T1D (monitored up to 38 days from the disease induction), and fluorescent histochemical analysis showed that their pancreatic islets expressed more insulin. PERA treatment significantly down-regulated the proportions of CD11b. These findings suggest that PERA efficiently prevented T1D development in mice. Interestingly, PERA attenuated the inflammatory process in the islets through temporally specific interference with the innate and adaptive immune response and therefore shows great promise for further clinical evaluation as a novel T1D therapeutic.

    Topics: Animals; Autoimmunity; Cinnamates; Depsides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Esters; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Phenylethyl Alcohol; Rosmarinic Acid

2022